US4359465A
(en)
*
|
1980-07-28 |
1982-11-16 |
The Upjohn Company |
Methods for treating gastrointestinal inflammation
|
CH644116A5
(de)
*
|
1980-08-21 |
1984-07-13 |
Hoffmann La Roche |
Imidazolderivate.
|
IL66340A
(en)
*
|
1981-08-13 |
1986-08-31 |
Haessle Ab |
Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
|
US4472409A
(en)
*
|
1981-11-05 |
1984-09-18 |
Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung |
2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
|
ZA828136B
(en)
*
|
1981-11-05 |
1983-09-28 |
Byk Gulden Lomberg Chem Fab |
Substituted benzimidazoles,a process for their preparation,their use,and medicaments containing them
|
DE3216843C2
(de)
*
|
1982-05-05 |
1986-10-23 |
Ludwig Heumann & Co GmbH, 8500 Nürnberg |
3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
SE8204879D0
(sv)
*
|
1982-08-26 |
1982-08-26 |
Haessle Ab |
Novel chemical intermediates
|
SE8300736D0
(sv)
*
|
1983-02-11 |
1983-02-11 |
Haessle Ab |
Novel pharmacologically active compounds
|
SE8301182D0
(sv)
*
|
1983-03-04 |
1983-03-04 |
Haessle Ab |
Novel compounds
|
HU195220B
(en)
*
|
1983-05-03 |
1988-04-28 |
Byk Gulden Lomberg Chem Fqb |
Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
|
HU193408B
(en)
*
|
1983-05-03 |
1987-10-28 |
Byk Gulden Lomberg Chem Fqb |
Process for production of new tree-cycle compounds
|
CA1259070A
(en)
*
|
1983-07-01 |
1989-09-05 |
Upjohn Company (The) |
Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles
|
US5077407A
(en)
*
|
1983-07-01 |
1991-12-31 |
The Upjohn Company |
Substituted 2-[monoannelated (3,4-,4,5-, and 5,6-) pyridylalkylenesulfinyl]benzimidazoles
|
DE3333314A1
(de)
*
|
1983-09-15 |
1985-03-28 |
Hoechst Ag, 6230 Frankfurt |
Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
|
US4663347A
(en)
|
1983-10-31 |
1987-05-05 |
Merck Frosst Canada, Inc. |
Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
|
US4575554A
(en)
*
|
1983-12-05 |
1986-03-11 |
The Upjohn Company |
Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
|
ZW4585A1
(en)
*
|
1984-04-19 |
1985-11-20 |
Hoffmann La Roche |
Imidazole derivatives
|
SE8403179D0
(sv)
*
|
1984-06-13 |
1984-06-13 |
Haessle Ab |
New compounds
|
IL75400A
(en)
*
|
1984-06-16 |
1988-10-31 |
Byk Gulden Lomberg Chem Fab |
Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
|
CA1341314C
(en)
*
|
1984-07-06 |
2001-11-06 |
David Cox |
Derivatives of benzimidazole, benzothiazole and benzoxazole
|
SE8404065D0
(sv)
*
|
1984-08-10 |
1984-08-10 |
Haessle Ab |
Novel biologically active compounds
|
JPS6150978A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
JPS6150979A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
US4619997A
(en)
*
|
1984-09-06 |
1986-10-28 |
The Upjohn Company |
Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
|
KR890000387B1
(ko)
*
|
1984-09-24 |
1989-03-16 |
디 엎존 캄파니 |
2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
|
SE8405588D0
(sv)
*
|
1984-11-08 |
1984-11-08 |
Haessle Ab |
New compounds
|
EP0187977B1
(en)
*
|
1984-12-18 |
1990-08-29 |
Otsuka Pharmaceutical Co., Ltd. |
Tetrahydroquinoline derivatives, process for preparing the same and anti-peptic ulcer compositions containg the same
|
FI861772A
(fi)
*
|
1985-05-07 |
1986-11-08 |
Chemie Linz Ag |
Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
|
EP0204215B1
(en)
|
1985-05-24 |
1993-08-11 |
G.D. Searle & Co. |
2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
|
US5869513A
(en)
*
|
1985-05-24 |
1999-02-09 |
G. D. Searle & Co. |
2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
|
CA1309557C
(en)
|
1985-06-18 |
1992-10-27 |
Robert N. Young |
Leukotriene antagonists
|
US4738975A
(en)
*
|
1985-07-02 |
1988-04-19 |
Takeda Chemical Industries, Ltd. |
Pyridine derivatives, and use as anti-ulcer agents
|
AR243167A1
(es)
|
1985-08-24 |
1993-07-30 |
Hoechst Ag |
Procedimiento para la preparacion de toluidinas sustituidas.
|
JPS6261978A
(ja)
*
|
1985-09-12 |
1987-03-18 |
Otsuka Pharmaceut Co Ltd |
5−フルオロ−1h−ベンズイミダゾ−ル誘導体
|
SE8505112D0
(sv)
*
|
1985-10-29 |
1985-10-29 |
Haessle Ab |
Novel pharmacological compounds
|
US6749864B2
(en)
*
|
1986-02-13 |
2004-06-15 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
CA1327010C
(en)
*
|
1986-02-13 |
1994-02-15 |
Tadashi Makino |
Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
|
US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
ES2032394T3
(es)
*
|
1986-02-20 |
1993-02-16 |
Hoechst Aktiengesellschaft |
Procedimiento para preparar derivados de tienoimidazol sustituidos.
|
WO1987005296A1
(en)
*
|
1986-03-07 |
1987-09-11 |
Pfizer Inc. |
2-[(2-pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents
|
ATE90076T1
(de)
|
1986-03-27 |
1993-06-15 |
Merck Frosst Canada Inc |
Tetrahydrocarbazole ester.
|
GB2189698A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
GB2189699A
(en)
*
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
US4687775A
(en)
*
|
1986-07-17 |
1987-08-18 |
G. D. Searle & Co. |
2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
|
US4772619A
(en)
*
|
1986-07-17 |
1988-09-20 |
G. D. Searle & Co. |
[(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
|
US4721718A
(en)
*
|
1986-08-18 |
1988-01-26 |
G. D. Searle & Co. |
2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
|
CA1256109A
(en)
*
|
1986-09-10 |
1989-06-20 |
Franz Rovenszky |
Process for the preparation of derivatives of 4, 5-dihydrooxazoles
|
SE8604566D0
(sv)
*
|
1986-10-27 |
1986-10-27 |
Haessle Ab |
Novel compunds
|
FI90544C
(fi)
*
|
1986-11-13 |
1994-02-25 |
Eisai Co Ltd |
Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
|
EP0786461A1
(en)
*
|
1986-11-13 |
1997-07-30 |
Eisai Co., Ltd. |
Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same
|
NZ234564A
(en)
|
1986-11-21 |
1991-04-26 |
Haessle Ab |
1-substituted benzimidazoles and pharmaceutical compositions
|
SE8604998D0
(sv)
|
1986-11-21 |
1986-11-21 |
Haessle Ab |
Novel pharmacological compounds
|
DE3639926A1
(de)
*
|
1986-11-22 |
1988-06-01 |
Hoechst Ag |
Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
|
FI91754C
(fi)
*
|
1986-12-02 |
1994-08-10 |
Tanabe Seiyaku Co |
Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
|
JPS63230633A
(ja)
*
|
1987-03-19 |
1988-09-27 |
Nippon Chemiphar Co Ltd |
胃腸の細胞保護剤
|
DE3719783A1
(de)
*
|
1987-06-13 |
1988-12-22 |
Hoechst Ag |
Verfahren zur herstellung von 5-phenylsulfinyl-1h-2-(methoxycarbonylamino)- benzimidazol
|
JP2718945B2
(ja)
*
|
1987-06-17 |
1998-02-25 |
エーザイ株式会社 |
ピリジン誘導体及びそれを含有する潰瘍治療剤
|
FI96860C
(fi)
*
|
1987-06-17 |
1996-09-10 |
Eisai Co Ltd |
Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
|
DE3723327A1
(de)
*
|
1987-07-15 |
1989-02-02 |
Hoechst Ag |
Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
|
DK171989B1
(da)
*
|
1987-08-04 |
1997-09-08 |
Takeda Chemical Industries Ltd |
Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
|
US5124158A
(en)
*
|
1988-06-30 |
1992-06-23 |
The Upjohn Company |
Transdermal antisecretory agents for gastrointestinal disease
|
US5223515A
(en)
*
|
1988-08-18 |
1993-06-29 |
Takeda Chemical Industries, Ltd. |
Injectable solution containing a pyridyl methylsulfinylbenzimidazole
|
WO1990002124A1
(en)
*
|
1988-08-23 |
1990-03-08 |
Aktiebolaget Hässle |
Treatment of glaucoma and related disorders in the human eye with pyridinylmethyl (sulfinyl or thio)benzimidazoles
|
US5075323A
(en)
*
|
1988-08-24 |
1991-12-24 |
Aktiebolaget Hassle |
Compounds including omeprazole in the treatment of glaucoma
|
WO1990003373A1
(en)
*
|
1988-09-20 |
1990-04-05 |
Hisamitsu Pharmaceutical Co., Inc. |
NOVEL DIBENZ[b,e]OXEPIN DERIVATIVES
|
AT391693B
(de)
*
|
1988-11-15 |
1990-11-12 |
Cl Pharma |
Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
|
SE8804628D0
(sv)
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New compounds
|
SE8804629D0
(sv)
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New therapeutically active compounds
|
IE64199B1
(en)
*
|
1988-12-22 |
1995-07-12 |
Haessle Ab |
Compound with gastric acid inhibitory effect and process for its preparation
|
JP2694361B2
(ja)
*
|
1989-02-09 |
1997-12-24 |
アストラ アクチエボラグ |
抗菌剤
|
GB2239453A
(en)
*
|
1989-11-27 |
1991-07-03 |
Haessle Ab |
Omeprazole
|
US5274099A
(en)
*
|
1989-12-20 |
1993-12-28 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US5049674A
(en)
*
|
1989-12-20 |
1991-09-17 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US4965269A
(en)
*
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
KR930000861B1
(ko)
*
|
1990-02-27 |
1993-02-08 |
한미약품공업 주식회사 |
오메프라졸 직장투여 조성물
|
JP2733138B2
(ja)
|
1990-04-04 |
1998-03-30 |
カイロン コーポレイション |
抗hcv抗体の免疫アッセイに使用するc型肝炎ウイルス(hcv)抗原の組合せ
|
SE9002043D0
(sv)
*
|
1990-06-07 |
1990-06-07 |
Astra Ab |
Improved method for synthesis
|
SE9002206D0
(sv)
|
1990-06-20 |
1990-06-20 |
Haessle Ab |
New compounds
|
CA2083606C
(en)
*
|
1990-06-20 |
2001-08-21 |
Arne Elof Brandstrom |
Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
|
US5061805A
(en)
*
|
1990-08-10 |
1991-10-29 |
Reilly Industries, Inc. |
Process for preparing 2-methyl-3,5-dialkylpyridines by dealkylation with sulfur
|
CA2052698A1
(en)
*
|
1990-10-11 |
1992-04-12 |
Roger G. Berlin |
Treatment of peptic ulcer
|
CA2053216C
(en)
|
1990-10-12 |
2003-04-08 |
Michel L. Belley |
Saturated hydroxyalkylquinoline acids as leukotriene antagonists
|
DE69132082T2
(de)
|
1990-10-17 |
2000-08-31 |
Takeda Chemical Industries Ltd |
Pyridin-Derivate, Verfahren zu deren Herstellung und Anwendung
|
ES2026761A6
(es)
*
|
1990-10-31 |
1992-05-01 |
Genesis Para La Investigacion |
Procedimiento de obtencion del omeprazol.
|
NZ244301A
(en)
*
|
1991-09-20 |
1994-08-26 |
Merck & Co Inc |
Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
|
FR2692146B1
(fr)
*
|
1992-06-16 |
1995-06-02 |
Ethypharm Sa |
Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
|
EP0649305A1
(en)
*
|
1992-07-08 |
1995-04-26 |
Monsanto Company |
Benzimidazoles for alleviating stomach ulcers in swine
|
DE69305642T2
(de)
*
|
1992-07-28 |
1997-02-27 |
Astra Ab, Soedertaelje |
Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
SE9302396D0
(sv)
*
|
1993-07-09 |
1993-07-09 |
Ab Astra |
A novel compound form
|
SE9302395D0
(sv)
*
|
1993-07-09 |
1993-07-09 |
Ab Astra |
New pharmaceutical formulation
|
US5410054A
(en)
*
|
1993-07-20 |
1995-04-25 |
Merck Frosst Canada, Inc. |
Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
|
TW280770B
(no)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
CA2175235A1
(en)
*
|
1993-10-29 |
1995-05-04 |
Takeshi Kawakita |
Pyridine compound and medicinal use thereof
|
US5374730A
(en)
*
|
1993-11-04 |
1994-12-20 |
Torcan Chemical Ltd. |
Preparation of omeprazole and lansoprazole
|
US5502195A
(en)
*
|
1993-11-04 |
1996-03-26 |
Slemon; Clarke |
Sulfoxide-carboxylate intermediates of omeprazole and lansoprazole
|
KR0142815B1
(ko)
*
|
1994-12-02 |
1998-07-15 |
정도언 |
신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
|
KR0179401B1
(ko)
*
|
1994-02-28 |
1999-03-20 |
송택선 |
신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
|
WO1995029897A1
(en)
*
|
1994-04-29 |
1995-11-09 |
G.D. Searle & Co. |
METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
UA41946C2
(uk)
*
|
1994-07-08 |
2001-10-15 |
Астра Актієболаг |
Оральна фармацевтична складова одинична дозована форма у вигляді таблетки, спосіб її одержання, упаковка у вигляді блістера та спосіб інгібування секреції шлункової кислоти і/або лікування шлунково-кишкових запальних захворювань
|
SE504459C2
(sv)
*
|
1994-07-15 |
1997-02-17 |
Astra Ab |
Förfarande för framställning av substituerade sulfoxider
|
GB9423970D0
(en)
*
|
1994-11-28 |
1995-01-11 |
Astra Ab |
Oxidation
|
GB9423968D0
(en)
*
|
1994-11-28 |
1995-01-11 |
Astra Ab |
Resolution
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
JP3015702B2
(ja)
*
|
1995-02-21 |
2000-03-06 |
株式会社アラクス |
イミダゾール誘導体及びそれらの薬剤として許容される酸付加塩及びその製造法並びにそれらを有効成分とする抗潰瘍剤
|
JP3046924B2
(ja)
*
|
1995-03-27 |
2000-05-29 |
株式会社アラクス |
イミダゾリン誘導体又はそれらの可能な互変異性体及びそれらの製造方法並びにそれらを有効成分とする創傷治療薬
|
US5708017A
(en)
*
|
1995-04-04 |
1998-01-13 |
Merck & Co., Inc. |
Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
|
HRP960232A2
(en)
*
|
1995-07-03 |
1998-02-28 |
Astra Ab |
A process for the optical purification of compounds
|
US5686588A
(en)
*
|
1995-08-16 |
1997-11-11 |
Yoo; Seo Hong |
Amine acid salt compounds and process for the production thereof
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
PL186605B1
(pl)
*
|
1995-09-21 |
2004-01-30 |
Pharma Pass Llc |
Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol
|
SE521100C2
(sv)
*
|
1995-12-15 |
2003-09-30 |
Astra Ab |
Förfarande för framställning av en bensimidazolförening
|
KR970032861A
(ko)
*
|
1995-12-29 |
1997-07-22 |
김준웅 |
헬리코박터 피로리 제거용 약제 투여방법
|
US20050054682A1
(en)
*
|
1996-01-04 |
2005-03-10 |
Phillips Jeffrey O. |
Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
WO1997029103A2
(en)
*
|
1996-02-06 |
1997-08-14 |
Pdi-Research Laboratories, Inc. |
Synthesis of omeprazole-type pyridine derivatives and intermediates thereof
|
US6623759B2
(en)
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
US5625069A
(en)
*
|
1996-07-22 |
1997-04-29 |
Development Center For Biotechnology |
Process for preparing 2-cyano-3,5-dimethyl-4-methoxypyridine
|
US6380222B2
(en)
|
1996-10-11 |
2002-04-30 |
Astrazeneca Ab |
Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
|
TW385306B
(en)
*
|
1996-11-14 |
2000-03-21 |
Takeda Chemical Industries Ltd |
Method for producing crystals of benzimidazole derivatives
|
SE510666C2
(sv)
*
|
1996-12-20 |
1999-06-14 |
Astra Ab |
Nya Kristallmodifikationer
|
CA2204580A1
(en)
*
|
1997-05-06 |
1998-11-06 |
Michel Zoghbi |
Synthesis of pharmaceutically useful pyridine derivatives
|
US6437139B1
(en)
|
1997-05-06 |
2002-08-20 |
Pdi-Research Laboratories, Inc. |
Synthesis of pharmaceutically useful pyridine derivatives
|
KR100463031B1
(ko)
*
|
1997-05-26 |
2005-04-06 |
동아제약주식회사 |
5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
|
SE9702000D0
(sv)
*
|
1997-05-28 |
1997-05-28 |
Astra Ab |
New pharmaceutical formulation
|
EP0983263A1
(en)
*
|
1997-05-30 |
2000-03-08 |
Dr. Reddy's Research Foundation |
Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
US6747155B2
(en)
|
1997-05-30 |
2004-06-08 |
Astrazeneca Ab |
Process
|
SE510643C2
(sv)
|
1997-06-27 |
1999-06-14 |
Astra Ab |
Termodynamiskt stabil omeprazol natrium form B
|
KR100570104B1
(ko)
*
|
1997-07-11 |
2006-04-11 |
에자이 가부시키가이샤 |
피리딘 유도체의 제조방법
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
EP1003554B1
(en)
|
1997-07-25 |
2004-11-03 |
ALTANA Pharma AG |
Proton pump inhibitor in therapeutic combination with antibacterial substances
|
US6296876B1
(en)
|
1997-10-06 |
2001-10-02 |
Isa Odidi |
Pharmaceutical formulations for acid labile substances
|
US7230014B1
(en)
*
|
1997-10-14 |
2007-06-12 |
Eisai Co., Ltd. |
Pharmaceutical formulation comprising glycine as a stabilizer
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9704183D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New process
|
DE19754324A1
(de)
*
|
1997-12-08 |
1999-06-10 |
Byk Gulden Lomberg Chem Fab |
Neue Darreichungsform enthaltend einen säurelabilen Wirkstoff
|
ATE500815T1
(de)
|
1997-12-08 |
2011-03-15 |
Dietrich Rango |
Neue suppositoriumsform mit säureempfindlichem wirkstoff
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
US6159968A
(en)
*
|
1998-01-15 |
2000-12-12 |
University Of Cincinnati |
Activation of chloride channels for correction of defective chloride transport
|
KR100396431B1
(ko)
*
|
1998-01-26 |
2003-09-02 |
가부시키가이샤 구라레 |
2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1h-벤즈이
|
US6350876B2
(en)
|
1998-01-26 |
2002-02-26 |
Kuraray Co., Ltd. |
4-chloro-3,5-dimethyl-2-sulfonyl pyridines
|
IT1299198B1
(it)
|
1998-03-05 |
2000-02-29 |
Nicox Sa |
Sali nitrati di farmaci antiulcera
|
ES2559766T3
(es)
|
1998-05-18 |
2016-02-15 |
Takeda Pharmaceutical Company Limited |
Comprimidos disgregables en la boca
|
US6303787B1
(en)
|
1998-05-27 |
2001-10-16 |
Natco Pharma Limited |
Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
|
ZA9810765B
(en)
*
|
1998-05-28 |
1999-08-06 |
Ranbaxy Lab Ltd |
Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
|
AU4387799A
(en)
*
|
1998-06-26 |
2000-01-17 |
Russinsky Limited |
Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
|
SI20019A
(sl)
*
|
1998-07-13 |
2000-02-29 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
|
ID28273A
(id)
|
1998-08-10 |
2001-05-10 |
Partnership Of Michael E Garst |
Prodrug inhibitor pompa proton
|
US6093734A
(en)
*
|
1998-08-10 |
2000-07-25 |
Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin |
Prodrugs of proton pump inhibitors
|
US6191148B1
(en)
*
|
1998-08-11 |
2001-02-20 |
Merck & Co., Inc. |
Omerazole process and compositions thereof
|
US6166213A
(en)
*
|
1998-08-11 |
2000-12-26 |
Merck & Co., Inc. |
Omeprazole process and compositions thereof
|
SI1105105T1
(sl)
|
1998-08-12 |
2006-08-31 |
Altana Pharma Ag |
Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
US6733778B1
(en)
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9803772D0
(sv)
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
AU1054899A
(en)
*
|
1998-11-06 |
2000-05-29 |
Dong-A Pharmaceutical Co., Ltd. |
Method of preparing sulfide derivatives
|
IL142703A
(en)
|
1998-11-10 |
2006-04-10 |
Astrazeneca Ab |
Crystalline form of omeprazole
|
UA72748C2
(en)
*
|
1998-11-10 |
2005-04-15 |
Astrazeneca Ab |
A novel crystalline form of omeprazole
|
JP3926936B2
(ja)
|
1998-11-16 |
2007-06-06 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スルホキシド誘導体・アセトン錯体およびその製造法
|
SE9900274D0
(sv)
*
|
1999-01-28 |
1999-01-28 |
Astra Ab |
New compound
|
US6852739B1
(en)
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
TWI243672B
(en)
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
ATE300285T1
(de)
|
1999-06-07 |
2005-08-15 |
Altana Pharma Ag |
Neue zubereitung und darreichungsform enthaltend einen säurelabilen protonenpumpeninhibitor
|
IL130602A0
(en)
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
CA2382838A1
(en)
*
|
1999-08-26 |
2001-03-01 |
Frederick D. Sancilio |
Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
EP1595879A3
(en)
*
|
1999-08-26 |
2010-01-27 |
aaiPharma Inc. |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
JP4312405B2
(ja)
*
|
1999-08-26 |
2009-08-12 |
エイエイアイファーマ・インコーポレイテッド |
アルコキシ置換ベンズイミダゾール化合物、それを含む医薬製剤物、およびそれを使用する方法
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6228400B1
(en)
|
1999-09-28 |
2001-05-08 |
Carlsbad Technology, Inc. |
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
|
SE9903831D0
(sv)
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
DE19951960C2
(de)
*
|
1999-10-28 |
2002-06-27 |
Gruenenthal Gmbh |
Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
|
CA2290893C
(en)
|
1999-11-16 |
2007-05-01 |
Bernard Charles Sherman |
Magnesium omeprazole
|
DE19959419A1
(de)
|
1999-12-09 |
2001-06-21 |
Ratiopharm Gmbh |
Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
|
WO2001044257A1
(en)
*
|
1999-12-17 |
2001-06-21 |
Ariad Pharmaceuticals, Inc. |
Proton pump inhibitors
|
US6787342B2
(en)
|
2000-02-16 |
2004-09-07 |
Merial Limited |
Paste formulations
|
SE0000774D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
SE0000773D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
SE0002476D0
(sv)
|
2000-06-30 |
2000-06-30 |
Astrazeneca Ab |
New compounds
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
WO2002045692A1
(en)
|
2000-12-07 |
2002-06-13 |
Altana Pharma Ag |
Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
|
JP2004514737A
(ja)
|
2000-12-07 |
2004-05-20 |
アルタナ ファルマ アクチエンゲゼルシャフト |
酸分解性活性成分を含有する迅速に崩壊する錠剤
|
CA2430816C
(en)
|
2000-12-07 |
2012-05-15 |
Altana Pharma Ag |
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
|
US7129358B2
(en)
|
2001-02-02 |
2006-10-31 |
Teva Pharmaceutical Industries Ltd. |
Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
|
US6645946B1
(en)
|
2001-03-27 |
2003-11-11 |
Pro-Pharmaceuticals, Inc. |
Delivery of a therapeutic agent in a formulation for reduced toxicity
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
SI20875A
(sl)
*
|
2001-04-25 |
2002-10-31 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Kristalna oblika omeprazola
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
EP2260837A1
(en)
*
|
2001-06-01 |
2010-12-15 |
Pozen, Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
DE10140492A1
(de)
|
2001-08-17 |
2003-08-14 |
Gruenenthal Gmbh |
Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
EP1428825A4
(en)
*
|
2001-09-18 |
2005-03-23 |
Zeria Pharm Co Ltd |
benzimidazole derivatives
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
WO2003032953A1
(fr)
|
2001-10-17 |
2003-04-24 |
Takeda Chemical Industries, Ltd. |
Granules contenant un agent chimique instable en milieu acide, en concentration elevee
|
US7855082B1
(en)
|
2001-10-31 |
2010-12-21 |
Astrazeneca Ab |
Raman spectroscopic method for determining the ratio of 5-methoxy and 6-methoxy isomers of omeprazole
|
MXPA04007169A
(es)
*
|
2002-01-25 |
2004-10-29 |
Santarus Inc |
Suministro transmucosal de inhibidores de bomba de protones.
|
ES2286408T3
(es)
*
|
2002-03-05 |
2007-12-01 |
Astrazeneca Ab |
Sales de alquilamonio de omeprazol e esomeprazol.
|
PT1492511E
(pt)
|
2002-04-09 |
2009-04-09 |
Flamel Tech Sa |
Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
|
CA2480824A1
(fr)
|
2002-04-09 |
2003-10-16 |
Flamel Technologies |
Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
US20040034078A1
(en)
*
|
2002-06-14 |
2004-02-19 |
Agouron Pharmaceuticals, Inc. |
Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase
|
MXPA05000657A
(es)
*
|
2002-07-19 |
2005-08-19 |
Winston Pharmaceuticals Llc |
Profarmacos de los inhibidores de bomba de protones.
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
JP4634144B2
(ja)
*
|
2002-08-01 |
2011-02-16 |
ニコックス エスエー |
ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
|
EP1552833B1
(en)
|
2002-10-16 |
2016-12-28 |
Takeda Pharmaceutical Company Limited |
Process for producing an amorphous optically active isomer of lansoprazole
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
SE0203092D0
(en)
*
|
2002-10-18 |
2002-10-18 |
Astrazeneca Ab |
Method for the synthesis of a benzimidazole compound
|
FR2845915B1
(fr)
|
2002-10-21 |
2006-06-23 |
Negma Gild |
Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
|
EP1556043A1
(en)
*
|
2002-10-22 |
2005-07-27 |
Ranbaxy Laboratories, Ltd. |
Amorphous form of esomeprazole salts
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
PT1578742E
(pt)
|
2002-12-06 |
2013-01-24 |
Nycomed Gmbh |
Processo para preparar compostos activos opticamente puros
|
BR0316702A
(pt)
|
2002-12-06 |
2005-10-18 |
Altana Pharma Ag |
xprocesso para preparação de (s)-pantoprazol
|
FR2848555B1
(fr)
|
2002-12-16 |
2006-07-28 |
Negma Gild |
Enantiomere(-)du tenatoprazole et son application en therapeutique
|
WO2004056804A2
(en)
*
|
2002-12-19 |
2004-07-08 |
Teva Pharmaceutical Industries Ltd. |
Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
|
WO2004066924A2
(en)
*
|
2003-01-24 |
2004-08-12 |
Andrx Labs Llc |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
TWI367759B
(en)
*
|
2003-02-20 |
2012-07-11 |
Santarus Inc |
A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
|
US20040185119A1
(en)
*
|
2003-02-26 |
2004-09-23 |
Theuer Richard C. |
Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
|
WO2004080961A2
(en)
*
|
2003-03-12 |
2004-09-23 |
Teva Pharmaceutical Industries Ltd. |
Crystalline and amorphous solids of pantoprazole and processes for their preparation
|
EP1611901B1
(en)
*
|
2003-03-13 |
2013-07-10 |
Eisai R&D Management Co., Ltd. |
Preventive or remedy for teeth grinding
|
US20040185092A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Yih Ming Hsiao |
Pharmaceutical preparations of omeprazole and/or clarithromycin for oral use
|
FR2852956B1
(fr)
*
|
2003-03-28 |
2006-08-04 |
Negma Gild |
Procede de preparation enantioselective de derives de sulfoxydes
|
KR20060002878A
(ko)
*
|
2003-03-28 |
2006-01-09 |
지뎀 파마 |
술폭시화물 유도체의 광학 선택적 제조 방법
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
US7524837B2
(en)
*
|
2003-05-12 |
2009-04-28 |
Janssen Pharmaceutica N.V. |
Benzotriazapinone salts and methods for using same
|
CA2528993A1
(en)
*
|
2003-06-10 |
2004-12-23 |
Teva Pharmaceutical Industries Ltd. |
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
|
US8802139B2
(en)
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
CA2532104A1
(en)
*
|
2003-07-15 |
2005-02-24 |
Allergan, Inc. |
Process for preparing isomerically pure prodrugs of proton pump inhibitors
|
CA2531564C
(en)
*
|
2003-07-18 |
2016-01-19 |
Santarus, Inc. |
Pharmaceutical composition for inhibiting acid secretion
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
AU2004257864A1
(en)
*
|
2003-07-18 |
2005-01-27 |
Santarus, Inc. |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
US20050232992A1
(en)
*
|
2003-09-03 |
2005-10-20 |
Agi Therapeutics Limited |
Proton pump inhibitor formulations, and methods of preparing and using such formulations
|
SE0302381D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts I
|
SE0302382D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts II
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
WO2005039640A1
(en)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
CN1898569A
(zh)
*
|
2003-10-24 |
2007-01-17 |
伊缪因艾德有限公司 |
治疗方法
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
EP1716136A1
(en)
|
2004-02-11 |
2006-11-02 |
Ulkar Kimya Sanayii Ve Ticaret A.S. |
Pyridine benzimidazole sulfoxides of high purity
|
EP1715861A2
(en)
*
|
2004-02-18 |
2006-11-02 |
Allergan, Inc. |
Compositions comprising prodrugs of proton pump inhibitors
|
US20070161679A1
(en)
*
|
2004-02-18 |
2007-07-12 |
Allergan, Inc. |
Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
|
SE0400410D0
(sv)
|
2004-02-20 |
2004-02-20 |
Astrazeneca Ab |
New compounds
|
US20080287502A1
(en)
*
|
2004-03-30 |
2008-11-20 |
Dermatrends, Inc. |
Transdermal Administration of Proton Pump Inhibitors
|
PT1740571E
(pt)
|
2004-04-28 |
2009-09-02 |
Hetero Drugs Ltd |
Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050267157A1
(en)
*
|
2004-05-28 |
2005-12-01 |
David White |
Magnesium-S-omeprazole
|
EP1748998B1
(en)
|
2004-05-28 |
2010-01-27 |
Hetero Drugs Limited |
A novel stereoselective synthesis of benzimidazole sulfoxides
|
CN1960987A
(zh)
*
|
2004-06-02 |
2007-05-09 |
奥坦纳医药公司 |
制备吡啶-2-基甲基亚磺酰基-1h-苯并咪唑类化合物的方法
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
CA2787378C
(en)
|
2004-09-13 |
2015-11-03 |
Takeda Pharmaceutical Company Limited |
Method for producing lansoprazole crystal
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
CN101107013A
(zh)
|
2004-11-22 |
2008-01-16 |
阿纳迪斯有限公司 |
生物活性组合物
|
CN101111233A
(zh)
|
2004-12-23 |
2008-01-23 |
兰贝克赛实验室有限公司 |
稳定的口服苯并咪唑组合物及其制备方法
|
EP1845982A2
(en)
*
|
2005-02-02 |
2007-10-24 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions prepared by non-aqueous layering process
|
JP5124267B2
(ja)
|
2005-02-25 |
2013-01-23 |
武田薬品工業株式会社 |
顆粒の製造方法
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
US7803817B2
(en)
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US7563812B2
(en)
|
2005-06-15 |
2009-07-21 |
Hetero Drugs Limited |
Amorphous esomeprazole hydrate
|
WO2007004236A2
(en)
|
2005-07-04 |
2007-01-11 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
WO2007008588A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Dr. Reddy's Laboratories Ltd. |
Omeprazole form b
|
AR054583A1
(es)
*
|
2005-07-26 |
2007-06-27 |
Altana Pharma Ag |
Pantoprazol isotopicamente sustituido
|
US7601737B2
(en)
*
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
KR101358509B1
(ko)
*
|
2005-07-26 |
2014-02-05 |
다케다 게엠베하 |
동위 원소 치환된 양성자 펌프 억제제
|
AU2006299424A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties
|
US7576219B2
(en)
|
2005-10-26 |
2009-08-18 |
Hanmi Pharm. Co., Ltd |
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
|
AU2006323245B2
(en)
|
2005-12-05 |
2011-03-03 |
Astrazeneca Ab |
New process for the preparation of esomeprazole non-salt form
|
EP1801110A1
(en)
|
2005-12-22 |
2007-06-27 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Esomeprazole arginine salt
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
ES2325336T3
(es)
|
2005-12-28 |
2009-09-01 |
Union Quimico-Farmaceutica, S.A. |
Procedimiento para la preparacion del enantiomero (s) de omeprazol.
|
CA2634232C
(en)
|
2005-12-28 |
2013-08-20 |
Takeda Pharmaceutical Company Limited |
Method of producing solid preparation disintegrating in the oral cavity
|
WO2007112581A1
(en)
*
|
2006-04-03 |
2007-10-11 |
Isa Odidi |
Controlled release delivery device comprising an organosol coat
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US7786309B2
(en)
|
2006-06-09 |
2010-08-31 |
Apotex Pharmachem Inc. |
Process for the preparation of esomeprazole and salts thereof
|
US7863330B2
(en)
*
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
EP2046334B1
(en)
|
2006-07-25 |
2014-05-21 |
Vecta Ltd. |
Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
|
WO2008036201A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Alevium Pharmaceuticals, Inc. |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
GB2444593B
(en)
|
2006-10-05 |
2010-06-09 |
Santarus Inc |
Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
US20080103169A1
(en)
|
2006-10-27 |
2008-05-01 |
The Curators Of The University Of Missouri |
Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
|
SI2124884T1
(sl)
|
2006-12-22 |
2019-09-30 |
Ironwood Pharmaceuticals, Inc. |
Pripravki, ki obsegajo sekvestrante žolčnih kislin, za zdravljenje motenj požiralnika
|
EP1947099A1
(en)
|
2007-01-18 |
2008-07-23 |
LEK Pharmaceuticals D.D. |
Process for solvent removal from omeprazole salts
|
EP2114919A2
(en)
|
2007-01-31 |
2009-11-11 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic seperation
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
EP2125783A2
(en)
|
2007-02-21 |
2009-12-02 |
Cipla Limited |
Process for the preparation of esomeprazole magnesium dihydrate
|
CN101631768A
(zh)
*
|
2007-03-15 |
2010-01-20 |
太阳医药高级研究有限公司 |
新型前药
|
WO2008149204A1
(en)
*
|
2007-06-07 |
2008-12-11 |
Aurobindo Pharma Limited |
An improved process for preparing an optically active proton pump inhibitor
|
WO2009010937A1
(en)
*
|
2007-07-17 |
2009-01-22 |
Ranbaxy Laboratories Limited |
Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate
|
WO2009066317A2
(en)
*
|
2007-08-20 |
2009-05-28 |
Macleods Pharmaceuticals Limited |
Process for the preparation of pantoprazole sodium
|
US8106210B2
(en)
|
2007-10-08 |
2012-01-31 |
Hetero Drugs Limited |
Polymorphs of esomeprazole salts
|
CN101450939B
(zh)
*
|
2007-12-05 |
2013-06-19 |
沈阳药科大学 |
新型苯并咪唑类化合物
|
AU2009215514B9
(en)
|
2008-02-20 |
2014-01-30 |
The Curators Of The University Of Missouri |
Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
|
US8911787B2
(en)
|
2008-02-26 |
2014-12-16 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
BRPI0910627A2
(pt)
*
|
2008-04-15 |
2015-09-22 |
Schering Corp |
composições de alta densidade contendo posaconazol e formulações compreendendo as mesmas
|
WO2009129301A2
(en)
*
|
2008-04-15 |
2009-10-22 |
Schering Corporation |
Oral pharmaceutical compositions in a molecular solid dispersion
|
KR101044880B1
(ko)
*
|
2008-06-12 |
2011-06-28 |
일양약품주식회사 |
항궤양제 화합물의 합성에 유용한 중간체의 제조방법
|
EP2147918A1
(en)
|
2008-07-21 |
2010-01-27 |
LEK Pharmaceuticals D.D. |
Process for the preparation of S-omeprazole magnesium in a stable form
|
CH699302B1
(de)
*
|
2008-08-11 |
2012-03-15 |
Mepha Gmbh |
Orale pharmazeutische Formulierung für Omeprazol, enthaltend eine spezifische Trennschicht.
|
AU2009290712A1
(en)
|
2008-09-09 |
2010-03-18 |
Astrazeneca Ab |
Method for delivering a pharmaceutical composition to patient in need thereof
|
WO2010042785A1
(en)
*
|
2008-10-10 |
2010-04-15 |
Celtaxsys, Inc. |
Method of inducing negative chemotaxis
|
EP2264024A1
(en)
|
2008-10-14 |
2010-12-22 |
LEK Pharmaceuticals d.d. |
Process for the preparation of enantiomerically enriched proton pump inhibitors
|
WO2010134099A1
(en)
|
2009-05-21 |
2010-11-25 |
Cadila Healthcare Limited |
One pot process for preparing omeprazole and related compounds
|
ES2548508T3
(es)
|
2009-05-27 |
2015-10-19 |
Biotempus Limited |
Métodos de tratamiento de enfermedades
|
JP2012531430A
(ja)
*
|
2009-06-25 |
2012-12-10 |
ポーゼン インコーポレイテッド |
アスピリン療法を必要とする患者を治療するための方法
|
AU2010263304A1
(en)
|
2009-06-25 |
2012-02-02 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an NSAID-associated ulcer
|
WO2011058569A1
(en)
|
2009-11-12 |
2011-05-19 |
Hetero Research Foundation |
Process for the resolution of omeprazole
|
WO2011080501A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
EP2345408A3
(en)
|
2010-01-08 |
2012-02-29 |
Dr. Reddy's Laboratories Ltd. |
Acid labile drug formulations
|
CN102140099A
(zh)
|
2010-02-02 |
2011-08-03 |
山东轩竹医药科技有限公司 |
新的吡啶衍生物
|
US9623622B2
(en)
*
|
2010-02-24 |
2017-04-18 |
Michael Baines |
Packaging materials and methods
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9233103B2
(en)
|
2011-03-25 |
2016-01-12 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
|
JP6011982B2
(ja)
|
2011-08-26 |
2016-10-25 |
国立大学法人名古屋大学 |
骨形成促進剤及びその用途
|
EA028342B1
(ru)
|
2011-09-09 |
2017-11-30 |
Мерк Шарп И Доум Корп. |
Способы лечения пневмонии
|
WO2013081566A1
(en)
|
2011-11-25 |
2013-06-06 |
Mahmut Bilgic |
A formulation comprising benzimidazole
|
EP2601947A1
(en)
|
2011-12-05 |
2013-06-12 |
Abo Bakr Mohammed Ali Al-Mehdar |
Fixed-dose combination for treatment of helicobacter pylori associated diseases
|
CA2860231A1
(en)
|
2011-12-28 |
2013-07-04 |
Pozen Inc. |
Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
CN102584792B
(zh)
*
|
2012-01-06 |
2014-06-11 |
南京优科生物医药研究有限公司 |
制备高纯度的埃索美拉唑盐的方法
|
WO2013108068A1
(en)
|
2012-01-21 |
2013-07-25 |
Jubilant Life Sciences Limited |
Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers
|
US8809314B1
(en)
|
2012-09-07 |
2014-08-19 |
Cubist Pharmacueticals, Inc. |
Cephalosporin compound
|
US8476425B1
(en)
|
2012-09-27 |
2013-07-02 |
Cubist Pharmaceuticals, Inc. |
Tazobactam arginine compositions
|
WO2014113377A1
(en)
|
2013-01-15 |
2014-07-24 |
Ironwood Pharmaceuticals, Inc. |
Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
|
US9872906B2
(en)
|
2013-03-15 |
2018-01-23 |
Merck Sharp & Dohme Corp. |
Ceftolozane antibiotic compositions
|
US20140274996A1
(en)
|
2013-03-15 |
2014-09-18 |
Cubist Pharmaceuticals, Inc. |
Tazobactam and ceftolozane antibiotic compositions
|
US20140274994A1
(en)
|
2013-03-15 |
2014-09-18 |
Cubist Pharmaceuticals, Inc. |
Stabilizing ceftolozane
|
GB201306720D0
(en)
|
2013-04-12 |
2013-05-29 |
Special Products Ltd |
Formulation
|
EP3043797B1
(en)
|
2013-09-09 |
2020-04-08 |
Merck Sharp & Dohme Corp. |
Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
|
US20150094293A1
(en)
|
2013-09-27 |
2015-04-02 |
Calixa Therapeutics, Inc. |
Solid forms of ceftolozane
|
US9457011B2
(en)
|
2014-02-25 |
2016-10-04 |
Muslim D. Shahid |
Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor
|
FR3018812A1
(fr)
|
2014-03-21 |
2015-09-25 |
Minakem |
Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole
|
EP2933002A1
(en)
|
2014-04-11 |
2015-10-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical combinations of dabigatran and proton pump inhibitors
|
WO2015155307A1
(en)
|
2014-04-11 |
2015-10-15 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
|
CN104045627A
(zh)
*
|
2014-05-21 |
2014-09-17 |
丽珠医药集团股份有限公司 |
一种奥美拉唑纯化方法
|
CA2952069C
(en)
|
2014-06-16 |
2022-06-14 |
University Of Rochester |
Small molecule anti-scarring agents
|
WO2016126625A1
(en)
|
2015-02-03 |
2016-08-11 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
EP3288556A4
(en)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
US10736855B2
(en)
|
2016-02-25 |
2020-08-11 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
CA3033065A1
(en)
*
|
2016-08-11 |
2018-02-15 |
Adamis Pharmaceuticals Corporation |
Drug compositions
|
EP3292862A1
(en)
|
2016-09-07 |
2018-03-14 |
Sandoz Ag |
Omeprazole formulations
|
EP3512840B1
(en)
*
|
2016-09-14 |
2024-03-06 |
Yufeng Jane Tseng |
Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors
|
US11564910B2
(en)
|
2017-12-08 |
2023-01-31 |
Adamis Pharmaceuticals Corporation |
Drug compositions
|
CN110317164B
(zh)
*
|
2019-07-06 |
2022-08-19 |
抚州三和医药化工有限公司 |
一种奥美拉唑中间体的制备方法
|
EP4284374A1
(en)
|
2021-01-29 |
2023-12-06 |
Abbvie Inc. |
Methods of administrating elagolix
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|